{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:16:17Z","timestamp":1793502977778,"version":"4.5.0"},"reference-count":42,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T00:00:00Z","timestamp":1316476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Med Decis Making"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:p>Objective. To estimate the benefit of PSA-based screening for prostate cancer from the patient and societal perspectives. Method. A partially observable Markov decision process model was used to optimize PSA screening decisions. Age-specific prostate cancer incidence rates and the mortality rates from prostate cancer and competing causes were considered. The model trades off the potential benefit of early detection with the cost of screening and loss of patient quality of life due to screening and treatment. PSA testing and biopsy decisions are made based on the patient\u2019s probability of having prostate cancer. Probabilities are inferred based on the patient\u2019s complete PSA history using Bayesian updating. Data Sources. The results of all PSA tests and biopsies done in Olmsted County, Minnesota, from 1993 to 2005 (11,872 men and 50,589 PSA test results). Outcome Measures. Patients\u2019 perspective: to maximize expected quality-adjusted life years (QALYs); societal perspective: to maximize the expected monetary value based on societal willingness to pay for QALYs and the cost of PSA testing, prostate biopsies, and treatment. Results. From the patient perspective, the optimal policy recommends stopping PSA testing and biopsy at age 76. From the societal perspective, the stopping age is 71. The expected incremental benefit of optimal screening over the traditional guideline of annual PSA screening with threshold 4.0 ng\/mL for biopsy is estimated to be 0.165 QALYs per person from the patient perspective and 0.161 QALYs per person from the societal perspective. PSA screening based on traditional guidelines is found to be worse than no screening at all. Conclusions. PSA testing done with traditional guidelines underperforms and therefore underestimates the potential benefit of screening. Optimal screening guidelines differ significantly depending on the perspective of the decision maker.<\/jats:p>","DOI":"10.1177\/0272989x11416513","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T23:55:49Z","timestamp":1316562949000},"page":"337-349","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":37,"title":["Optimization of PSA Screening Policies"],"prefix":"10.1177","volume":"32","author":[{"given":"Jingyu","family":"Zhang","sequence":"first","affiliation":[{"name":"Philips Research North America, Briarcliff Manor, NY (JZ)"},{"name":"Edward P. Fitts Department of Industrial & Systems Engineering, North Carolina State University, Raleigh, NC (BTD)"},{"name":"Department of Mechanical & Industrial Engineering, University of Massachusetts, Amherst, MA (HB)"},{"name":"Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN (NDS)"},{"name":"Department of Surgery, School of Medicine, Duke University, Durham, NC (BAI)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Denton","sequence":"additional","affiliation":[{"name":"Philips Research North America, Briarcliff Manor, NY (JZ)"},{"name":"Edward P. Fitts Department of Industrial & Systems Engineering, North Carolina State University, Raleigh, NC (BTD)"},{"name":"Department of Mechanical & Industrial Engineering, University of Massachusetts, Amherst, MA (HB)"},{"name":"Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN (NDS)"},{"name":"Department of Surgery, School of Medicine, Duke University, Durham, NC (BAI)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari","family":"Balasubramanian","sequence":"additional","affiliation":[{"name":"Philips Research North America, Briarcliff Manor, NY (JZ)"},{"name":"Edward P. Fitts Department of Industrial & Systems Engineering, North Carolina State University, Raleigh, NC (BTD)"},{"name":"Department of Mechanical & Industrial Engineering, University of Massachusetts, Amherst, MA (HB)"},{"name":"Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN (NDS)"},{"name":"Department of Surgery, School of Medicine, Duke University, Durham, NC (BAI)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay D.","family":"Shah","sequence":"additional","affiliation":[{"name":"Philips Research North America, Briarcliff Manor, NY (JZ)"},{"name":"Edward P. Fitts Department of Industrial & Systems Engineering, North Carolina State University, Raleigh, NC (BTD)"},{"name":"Department of Mechanical & Industrial Engineering, University of Massachusetts, Amherst, MA (HB)"},{"name":"Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN (NDS)"},{"name":"Department of Surgery, School of Medicine, Duke University, Durham, NC (BAI)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brant A.","family":"Inman","sequence":"additional","affiliation":[{"name":"Philips Research North America, Briarcliff Manor, NY (JZ)"},{"name":"Edward P. Fitts Department of Industrial & Systems Engineering, North Carolina State University, Raleigh, NC (BTD)"},{"name":"Department of Mechanical & Industrial Engineering, University of Massachusetts, Amherst, MA (HB)"},{"name":"Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN (NDS)"},{"name":"Department of Surgery, School of Medicine, Duke University, Durham, NC (BAI)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2011,9,20]]},"reference":[{"key":"bibr1-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3537"},{"key":"bibr2-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.13.981"},{"key":"bibr3-0272989X11416513","doi-asserted-by":"crossref","unstructured":"Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605\u201313. Available from: URL: http:\/\/dx.doi.org\/10.1093\/jnci\/djq099","DOI":"10.1093\/jnci\/djq099"},{"key":"bibr4-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm153"},{"key":"bibr5-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.50.1.207"},{"key":"bibr6-0272989X11416513","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology, Prostate Cancer Eearly Detection V.2. 2007. Online booklet available at www.nccn.org."},{"key":"bibr7-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199909010-00032"},{"key":"bibr8-0272989X11416513","volume-title":"Prostate Specific Antigen Best Practice Statement: 2009 Update","author":"American Urological Association","year":"2009"},{"key":"bibr9-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511233332107"},{"key":"bibr10-0272989X11416513","doi-asserted-by":"crossref","unstructured":"Schroder FH, Hugosson J, Roobol MJ, Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320\u20138. Available from: URL: http:\/\/dx.doi.org\/10.1056\/NEJMoa0810084","DOI":"10.1056\/NEJMoa0810084"},{"key":"bibr11-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00008"},{"key":"bibr12-0272989X11416513","doi-asserted-by":"crossref","unstructured":"Andriole GL, Crawford ED, Grubb RL, Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310\u20139. Available from: URL: http:\/\/dx.doi.org\/10.1056\/NEJMoa0810696","DOI":"10.1056\/NEJMoa0810696"},{"key":"bibr13-0272989X11416513","doi-asserted-by":"crossref","unstructured":"Pinsky PF, Black A, Kramer BS, Miller A, Prorok PC, Berg C. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Clin Trials. 2010 June. Available from: URL: http:\/\/dx.doi.org\/10.1177\/1740774510374091","DOI":"10.1177\/1740774510374091"},{"key":"bibr14-0272989X11416513","doi-asserted-by":"crossref","unstructured":"Schroder FH, Roobol MJ. ERSPC and PLCO prostate cancer screening studies: what are the differences? Eur Urol. 2010 March. Available from: URL: http:\/\/dx.doi.org\/10.1016\/j.eururo.2010.03.033","DOI":"10.1016\/j.eururo.2010.03.033"},{"key":"bibr15-0272989X11416513","volume-title":"Optimization of Prostate Biopsy Referral Decisions","author":"Zhang J","year":"2009"},{"key":"bibr16-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1007\/BF02055574"},{"key":"bibr17-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.4065\/71.3.266"},{"key":"bibr18-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj131"},{"key":"bibr19-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.2307\/2530820"},{"key":"bibr20-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1053\/hp.2000.6698"},{"key":"bibr21-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.17.2095"},{"key":"bibr22-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.136"},{"key":"bibr23-0272989X11416513","unstructured":"National Cancer Institute. Surveillance epidemiology and end results [database]; 2008. Available from: URL: http:\/\/seer.cancer.gov\/"},{"key":"bibr24-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1287\/opre.1100.0877"},{"key":"bibr25-0272989X11416513","doi-asserted-by":"crossref","unstructured":"Kulkarni GS, Finelli A, Fleshner NE, Jewett MAS, Lopushinsky SR, Alibhai SMH. Optimal management of high-risk T1G3 bladder cancer: a decision analysis. PLoS Med. 2007;4(9):e284. Available from: URL: http:\/\/dx.doi.org\/10.1371\/journal.pmed.0040284","DOI":"10.1371\/journal.pmed.0040284"},{"key":"bibr26-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X07300604"},{"issue":"5","key":"bibr27-0272989X11416513","first-page":"1","volume":"56","author":"Heron M","year":"2007","journal-title":"National Vital Statistics Reports"},{"key":"bibr28-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.07.002"},{"issue":"4","key":"bibr29-0272989X11416513","first-page":"1","volume":"4","author":"Ekwueme DU","year":"2007","journal-title":"Prev Chronic Dis."},{"key":"bibr30-0272989X11416513","doi-asserted-by":"crossref","unstructured":"Draisma G, Etzioni R, Tsodikov A, Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst. 2009;101(6):374\u2013383. Available from: URL: http:\/\/dx.doi.org\/10.1093\/jnci\/djp001","DOI":"10.1093\/jnci\/djp001"},{"key":"bibr31-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X07312719"},{"key":"bibr32-0272989X11416513","doi-asserted-by":"crossref","unstructured":"Aus G, Bergdahl S, Lodding P, Lilja H, Hugosson J. Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer\u2014results from a prospective, population-based randomized controlled trial. Eur Urol. 2007;51(3):659\u2013664. Available from: URL: http:\/\/dx.doi.org\/10.1016\/j.eururo.2006.07.012","DOI":"10.1016\/j.eururo.2006.07.012"},{"key":"bibr33-0272989X11416513","doi-asserted-by":"crossref","unstructured":"McNaughton-Collins M, Fowler FJ, Caubet JF, Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med. 2004;117(10):719\u201325. Available from: URL: http:\/\/dx.doi.org\/10.1016\/j.amjmed.2004.06.036","DOI":"10.1016\/j.amjmed.2004.06.036"},{"key":"bibr34-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.11.1399"},{"key":"bibr35-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.1040.0287"},{"key":"bibr36-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X08329462"},{"key":"bibr37-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X04268956"},{"key":"bibr38-0272989X11416513","doi-asserted-by":"crossref","unstructured":"Alagoz O, Hsu H, Schaefer AJ, Roberts MS. Markov decision processes: a tool for sequential decision making under uncertainty. Med Decis Making. 2010;30(4):474\u201383. Available from: URL: http:\/\/dx.doi.org\/10.1177\/0272989X09353194","DOI":"10.1177\/0272989X09353194"},{"key":"bibr39-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1287\/opre.44.5.696"},{"key":"bibr40-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1016\/S0933-3657(99)00042-1"},{"key":"bibr41-0272989X11416513","doi-asserted-by":"publisher","DOI":"10.1287\/opre.1080.0614"},{"key":"bibr42-0272989X11416513","unstructured":"US Census Bureau. Annual estimates of the population by five-year age groups and sex for the United States: April 1, 2000 to July 1, 2006 (NC-EST2006-01) [database on the Internet]; 2006. Available from: URL: http:\/\/www.census.gov\/popest\/national\/asrh\/NC-EST2006-sa.html"}],"container-title":["Medical Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X11416513","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0272989X11416513","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X11416513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:55:30Z","timestamp":1777658130000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0272989X11416513"}},"subtitle":["A Comparison of the Patient and Societal Perspectives"],"short-title":[],"issued":{"date-parts":[[2011,9,20]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1177\/0272989X11416513"],"URL":"https:\/\/doi.org\/10.1177\/0272989x11416513","relation":{},"ISSN":["0272-989X","1552-681X"],"issn-type":[{"value":"0272-989X","type":"print"},{"value":"1552-681X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,20]]}}}